The differences between the biologics and small molecules include the molecular weight, structure, procedure of synthesis, and immunogenicity. Biologics have a higher molecular weight and a complex molecular structure.
They are usually derived from living entities, which is another important feature that differentiates it from small molecules. Biologics are also vulnerable to extreme temperatures (thermolabile) and light. The report analysts forecast the global biologic therapeutics market to grow at a CAGR of 8.26% over the period 2014-2019.
Covered in this report:
This report covers the present scenario and the growth prospects of the global biologic therapeutics market for the period 2015-2019. To calculate the market size, the report considers revenue generated through the sales protein therapeutics (monoclonal antibodies, enzymes, and other protein therapeutics). Other protein therapeutics covers proteins such as cytokines, fusion proteins, peptide antibiotics, peptide hormones, and blood factors.
The report also presents the vendor landscape and a corresponding detailed analysis of the top vendors in the market. The vendor landscape section includes a market share analysis of the major vendors along with the competitive performances of their product portfolios. In addition, the report discusses the major drivers that influence the growth of the market. It also outlines the challenges faced by the vendors and the market at large, as well as the key trends emerging in the market.
To Read more reports of this category:
http://www.radiantinsights.com/catalog/pharmaceutical
Global Biologic Therapeutics Market has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global biologic therapeutics market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.
Key regions
- Americas
- APAC
- EMEA
- Amgen
- F. Hoffmann-La Roche
- Novo Nordisk
- Sanofi
- AbbVie
- AstraZeneca
- Bavarian Nordic
- Baxter International
- Beijing Minhai Biotechnology
- Bharat Biotech
- Bharat Immunologicals and Biologicals
- Bio Med Pvt.
- bioCSL
- Biodel
- Bristol-Myers Squibb
- Diamyd Medical
- DiaVacs
- Dynavax Technologies
- Eli Lilly
- Generex Biotechnology
- Hualan Biological Engineering
- Imunoloski Zavod
- Indian Immunologicals
- Janssen
- JN International Medical
- Kaketsuken
- LG Life Sciences
- Macrogenics
- MannKind
- Merck
- Mitsubishi Tanabe Pharma
- Nuron Biotech
- Osiris Therapeutics
- Pfizer
- Protalix
- Protein Sciences
- Serum Institute of India
- Shenzhen Kangtai Biological Products
- Sinovac Biotech
- Tolerion
- Vacunas Finlay
- XOMA
- Zydus Cadila
- Reimbursement support for biologics
- For a full, detailed list, view our report
- High cost of therapy
- For a full, detailed list, view our report
Market trend
- Emergence of targeted and combination therapies
- For a full, detailed list, view our report
Key question answered in this report
- What will the market size be in 2019 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
No comments:
Post a Comment